Articles About amgen
April 06, 2014
Results presented at a meeting over the weekend show that a new class of cholesterol-lowering drugs could be the next weapon against high cholesterol levels.
April 03, 2014
One of Regeneron’s most promising Phase 3 products might not have a first-to-market advantage thanks to Amgen, and this could be bad news for the company.
March 31, 2014
Why is biotechnology underperforming, and should you step in and take advantage of these lower prices?